Title | Type | SJR | H index | Total Docs. (1999) | Total Docs. (3years) | Total Refs. (1999) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (1999) | %Female (1999) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
51 | Journal of Oral Pathology and Medicine | journal | 0.512 Q2 | 95 | 87 | 277 | 2651 | 351 | 276 | 1.24 | 30.47 | 24.31 | |
52 | Nitric Oxide - Biology and Chemistry | journal | 1.607 Q1 | 110 | 52 | 90 | 1818 | 340 | 89 | 3.78 | 34.96 | 26.40 | |
53 | Differentiation | journal | 1.195 Q1 | 107 | 43 | 131 | 2211 | 299 | 131 | 2.31 | 51.42 | 32.72 | |
54 | Tumori | journal | 0.252 Q3 | 59 | 146 | 460 | 3355 | 286 | 456 | 0.49 | 22.98 | 32.45 | |
55 | Journal of Immunotherapy | journal | 1.340 Q1 | 106 | 49 | 94 | 1950 | 278 | 93 | 2.79 | 39.80 | 28.40 | |
56 | Lung Cancer | journal | 0.378 Q3 | 148 | 86 | 255 | 2131 | 269 | 245 | 1.04 | 24.78 | 21.32 | |
57 | Japanese Journal of Clinical Oncology | journal | 0.332 Q3 | 95 | 154 | 352 | 2173 | 262 | 317 | 0.66 | 14.11 | 9.46 | |
58 | Journal of Mammary Gland Biology and Neoplasia | journal | 1.067 Q1 | 112 | 41 | 115 | 2508 | 252 | 114 | 2.13 | 61.17 | 41.18 | |
59 | Journal of the National Cancer Institute. Monographs | journal | 1.102 Q1 | 95 | 46 | 99 | 1349 | 246 | 99 | 3.76 | 29.33 | 40.70 | |
60 | Cancer Treatment and Research | journal | 0.331 Q3 | 65 | 44 | 290 | 3998 | 224 | 290 | 0.51 | 90.86 | 22.08 | |
61 | International Journal of Hyperthermia | journal | 0.645 Q2 | 98 | 40 | 181 | 1177 | 224 | 154 | 1.06 | 29.43 | 14.60 | |
62 | Journal of Immunotherapy | journal | 47 | 12 | 54 | 395 | 220 | 54 | 3.83 | 32.92 | 33.33 | ||
63 | European Journal of Cancer Part B: Oral Oncology | journal | 0.540 Q2 | 37 | 0 | 122 | 0 | 217 | 122 | 1.76 | 0.00 | 0.00 | |
64 | Tumor Biology | journal | 0.525 Q2 | 101 | 52 | 163 | 1385 | 216 | 163 | 1.29 | 26.63 | 24.12 | |
65 | Cancer Epidemiology | journal | 0.427 Q3 | 86 | 66 | 195 | 2388 | 207 | 195 | 0.91 | 36.18 | 28.26 | |
66 | Seminars in Radiation Oncology | journal | 0.737 Q2 | 103 | 63 | 125 | 2769 | 205 | 119 | 0.97 | 43.95 | 23.64 | |
67 | In Vivo | journal | 0.296 | 72 | 90 | 258 | 3341 | 204 | 257 | 0.88 | 37.12 | 26.06 | |
68 | Apoptosis : an international journal on programmed cell death | journal | 0.700 Q2 | 128 | 48 | 130 | 2463 | 202 | 130 | 1.44 | 51.31 | 36.31 | |
69 | Critical Reviews in Oncogenesis | journal | 2.858 Q1 | 57 | 11 | 51 | 3199 | 200 | 51 | 3.81 | 290.82 | 14.29 | |
70 | Bulletin du Cancer | journal | 0.174 Q4 | 44 | 175 | 472 | 4990 | 198 | 450 | 0.41 | 28.51 | 34.88 | |
71 | Recent Results in Cancer Research | book series | 0.345 Q3 | 63 | 10 | 224 | 804 | 182 | 224 | 0.75 | 80.40 | 27.78 | |
72 | Japanese Journal of Cancer and Chemotherapy | journal | 0.137 Q4 | 25 | 392 | 1247 | 2498 | 172 | 1245 | 0.12 | 6.37 | 5.59 | |
73 | Sub-Cellular Biochemistry | journal | 0.780 Q2 | 81 | 15 | 115 | 1397 | 169 | 115 | 1.54 | 93.13 | 12.50 | |
74 | Oral Oncology | journal | 0.351 Q3 | 137 | 99 | 134 | 3176 | 150 | 126 | 1.10 | 32.08 | 23.31 | |
75 | Cancer Chemotherapy and Pharmacology, Supplement | journal | 0.794 Q2 | 35 | 17 | 61 | 623 | 140 | 59 | 2.51 | 36.65 | 18.52 | |
76 | Neoplasma | journal | 0.246 Q3 | 57 | 112 | 208 | 2292 | 135 | 207 | 0.57 | 20.46 | 44.06 | |
77 | Advances in Biological Regulation | journal | 1.181 Q1 | 69 | 23 | 67 | 957 | 132 | 67 | 1.91 | 41.61 | 31.40 | |
78 | Breast | journal | 0.307 | 98 | 79 | 232 | 1413 | 129 | 222 | 0.53 | 17.89 | 28.76 | |
79 | Drug Resistance Updates | journal | 0.642 Q2 | 132 | 51 | 56 | 3305 | 109 | 48 | 1.95 | 64.80 | 24.73 | |
80 | Cancer Biotherapy and Radiopharmaceuticals | journal | 0.280 Q3 | 68 | 58 | 159 | 1859 | 106 | 141 | 0.76 | 32.05 | 25.86 | |
81 | Oncology Research and Treatment | journal | 0.145 Q4 | 55 | 93 | 366 | 2047 | 105 | 355 | 0.29 | 22.01 | 17.43 | |
82 | Invasion and Metastasis | journal | 0.555 Q2 | 31 | 11 | 76 | 419 | 102 | 76 | 0.96 | 38.09 | 31.25 | |
83 | Journal of Experimental and Clinical Cancer Research | journal | 0.193 Q4 | 120 | 91 | 231 | 2264 | 98 | 224 | 0.51 | 24.88 | 24.56 | |
84 | Medical Oncology | journal | 0.405 Q3 | 90 | 43 | 114 | 1641 | 94 | 111 | 0.73 | 38.16 | 32.16 | |
85 | Endocrine-Related Cancer | journal | 0.326 Q3 | 146 | 63 | 110 | 3043 | 93 | 108 | 0.81 | 48.30 | 34.71 | |
86 | Cancer Journal | journal | 0.166 Q4 | 16 | 0 | 156 | 0 | 82 | 142 | 0.49 | 0.00 | 0.00 | |
87 | Oncologist | journal | 0.229 Q4 | 189 | 67 | 180 | 2206 | 71 | 160 | 0.41 | 32.93 | 29.41 | |
88 | Journal of Biological Regulators and Homeostatic Agents | journal | 0.338 Q3 | 56 | 45 | 66 | 1356 | 69 | 64 | 1.04 | 30.13 | 48.42 | |
89 | Human Cell | journal | 0.351 Q3 | 44 | 26 | 107 | 390 | 68 | 107 | 0.47 | 15.00 | 9.86 | |
90 | Angiogenesis | journal | 0.572 Q2 | 101 | 39 | 49 | 1873 | 65 | 49 | 1.33 | 48.03 | 27.06 | |
91 | International Journal of Biological Markers | journal | 0.264 Q3 | 47 | 48 | 108 | 1281 | 54 | 86 | 0.50 | 26.69 | 41.89 | |
92 | Hematological Oncology | journal | 0.369 Q3 | 54 | 12 | 62 | 715 | 52 | 62 | 0.76 | 59.58 | 17.65 | |
93 | Current Problems in Cancer | journal | 0.575 Q2 | 47 | 14 | 29 | 544 | 41 | 28 | 2.29 | 38.86 | 0.00 | |
94 | Journal of Experimental Therapeutics and Oncology | journal | 0.352 Q3 | 40 | 0 | 48 | 0 | 41 | 48 | 0.00 | 0.00 | 0.00 | |
95 | Tumor Targeting | journal | 0.664 Q2 | 10 | 32 | 22 | 1183 | 41 | 21 | 1.86 | 36.97 | 31.07 | |
96 | Journal of Brachytherapy International | journal | 0.229 Q4 | 12 | 22 | 70 | 383 | 30 | 70 | 0.43 | 17.41 | 18.60 | |
97 | Brain Tumor Pathology | journal | 0.179 Q4 | 45 | 15 | 66 | 97 | 28 | 65 | 0.47 | 6.47 | 7.50 | |
98 | Journal of Tumor Marker Oncology | journal | 0.153 Q4 | 9 | 21 | 62 | 784 | 28 | 62 | 0.35 | 37.33 | 37.74 | |
99 | IARC monographs on the evaluation of carcinogenic risks to humans / World Health Organization, International Agency for Research on Cancer | book series | 0.236 Q3 | 50 | 142 | 45 | 8141 | 25 | 45 | 1.17 | 57.33 | 0.00 | |
100 | Molecular Imaging and Biology | journal | 0.353 Q3 | 78 | 35 | 25 | 894 | 25 | 25 | 1.00 | 25.54 | 18.88 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®